Sonoma Pharmaceuticals, Inc. Income Statement

Income Statement Mar2011 Mar2012
Revenue & cost
Revenue 9.75M12.74M
Cost of Revenue 3.61M4.03M
Gross Profit 6.14M8.71M
Operating items
Research & Development 2.05M1.98M
Selling, General & Administrative 11.60M13.20M
Operating Expenses 13.65M15.18M
Operating Income -7.50M-6.47M
EBIT -7.50M-6.47M
Non-operating items
Interest & Investment Income 0.00M0.00M
Net income details
EBT -7.91M-7.39M
Profit After Tax -7.95M-7.33M
Income from Continuing Operations -7.91M-7.39M
Consolidated Net Income -7.91M-7.39M
Income towards Parent Company -7.91M-7.39M
Net Income towards Common Stockholders -7.91M-7.39M
Additional items
EPS (Basic) -0.30-0.27
Shares Outstanding (Weighted Average) 0.00M0.00M
EBITDA -7.86M-7.48M
Interest Expenses 0.41M0.93M